Loading interactive trading data…

AKRO (Akero Therapeutics, Inc.): Congressional Trading Activity

Who traded AKRO?

AKRO (Akero Therapeutics, Inc.) appears in 1 STOCK Act disclosures from 1 filer (1 purchases, 0 sales), most recently Christopher L. Jacobs on Nov 8, 2022.

Disclosed trades

FilerTrade dateTypeAmount
Christopher L. JacobsNov 8, 2022Purchase$1,001 - $15,000

Congress Trading Monitor home